Future Diagnostics B.V.

Netherlands

Back to Profile

1-8 of 8 for Future Diagnostics B.V. Sort by
Query
Aggregations
Jurisdiction
        United States 4
        World 2
        Canada 2
Date
2021 1
Before 2021 7
IPC Class
G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins 8
G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor 4
C08F 14/26 - Tetrafluoroethene 2
G01N 1/28 - Preparing specimens for investigation 2
Found results for  patents

1.

Immunoassay for free vitamin D

      
Application Number 17150850
Grant Number 11927595
Status In Force
Filing Date 2021-01-15
First Publication Date 2021-05-06
Grant Date 2024-03-12
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Martens, Michaël Franciscus Wilhelmus Cornelis
  • Parsons, George Henry
  • Rosmalen, Franciscus Maria Anna
  • Swinkels, Leon Maria Jacobus Wilhelmus

Abstract

2. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins
  • G01N 1/28 - Preparing specimens for investigation
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor

2.

Immunoassay for free vitamin D

      
Application Number 15862318
Grant Number 10935557
Status In Force
Filing Date 2018-01-04
First Publication Date 2018-07-12
Grant Date 2021-03-02
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Martens, Michaël Franciscus Wilhelmus Cornelis
  • Parsons, George Henry
  • Rosmalen, Franciscus Maria Anna
  • Swinkels, Leon Maria Jacobus Wilhelmus

Abstract

Disclosed is the invention to conduct immuno-adsorption of free 25(OH) vitamin D from blood or blood components, notably serum or plasma, after which the absorbed material is measured. A fluoro-alkyl surfactant is used to enhance the solubility of Vitamin D and allow the measurement of free Vitamin D. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor
  • G01N 1/28 - Preparing specimens for investigation

3.

Release reagent for vitamin D

      
Application Number 13993285
Grant Number 10422805
Status In Force
Filing Date 2011-12-27
First Publication Date 2014-05-29
Grant Date 2019-09-24
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Swinkels, Leon Maria Jacobus Wilhelmus
  • Maas, Antonius Franciscus
  • Martens, Michael Franciscus Wilhelmus Cornelis

Abstract

Disclosed is an invention in the field of conducting an immunoassay of 25(OH) vitamin D in blood or blood components, notably serum or plasma. The invention employs a perfluoro alkyl acid, or a salt thereof, to release 25(OH) vitamin D from vitamin D binding protein. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins

4.

Immunoassay for free vitamin D

      
Application Number 13638613
Grant Number 09897615
Status In Force
Filing Date 2011-04-01
First Publication Date 2013-06-06
Grant Date 2018-02-20
Owner Future Diagnostics, B.V. (Netherlands)
Inventor
  • Martens, Michaël Franciscus Wilhelmus Cornelis
  • Parsons, George Henry
  • Rosmalen, Franciscus Maria Anna
  • Swinkels, Leon Maria Jacobus Wilhelmus

Abstract

Disclosed is the invention to conduct immuno-adsorption of free 25(OH) vitamin D from blood or blood components, notably serum or plasma, after which the absorbed material is measured. A fluoro-alkyl surfactant is used to enhance the solubility of Vitamin D and allow the measurement of free Vitamin D. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins

5.

RELEASE REAGENT FOR VITAMIN D

      
Document Number 02821415
Status In Force
Filing Date 2011-12-27
Open to Public Date 2012-07-05
Grant Date 2017-08-01
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Swinkels, Leon Maria Jacobus Wilhelmus
  • Maas, Antonius Franciscus
  • Martens, Michael Franciscus Wilhelmus Cornelis

Abstract

Disclosed is an invention in the field of conducting an immunoassay of 25(OH) vitamin D in blood or blood components, notably serum or plasma. The invention employs a perfluoro alkyl acid, or a salt thereof,to release 25(OH) vitamin D from vitamin D binding protein. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound.

IPC Classes  ?

  • C08F 14/26 - Tetrafluoroethene
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor
  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins

6.

RELEASE REAGENT FOR VITAMIN D

      
Application Number NL2011050905
Publication Number 2012/091569
Status In Force
Filing Date 2011-12-27
Publication Date 2012-07-05
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Swinkels, Leon Maria Jacobus Wilhelmus
  • Maas, Antonius Franciscus
  • Martens, Michaël Franciscus Wilhelmus Cornelis
  • Rosmalen, Franciscus Maria Anna

Abstract

Disclosed is an invention in the field of conducting an immunoassay of 25(OH) vitamin D in blood or blood components, notably serum or plasma. The invention employs a perfluoro alkyl acid, or a salt thereof,to release 25(OH) vitamin D from vitamin D binding protein. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound.

IPC Classes  ?

  • C08F 14/26 - Tetrafluoroethene
  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor

7.

IMMUNOASSAY FOR FREE VITAMIN D

      
Document Number 02794831
Status In Force
Filing Date 2011-04-01
Open to Public Date 2011-10-06
Grant Date 2017-06-20
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Martens, Michael Franciscus Wilhelmus Cornelis
  • Parsons, George Henry
  • Rosmalen, Franciscus Maria Anna
  • Swinkels, Leon Maria Jacobus Wilhelmus

Abstract

Disclosed is the invention to conduct immuno-adsorption of free 25(OH) vitamin D from blood or blood components, notably serum or plasma, after which the absorbed material is measured. A fluoro-alkyl surfactant is used to enhance the solubility of Vitamin D and allow the measurement of free Vitamin D. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins

8.

IMMUNOASSAY FOR FREE VITAMIN D

      
Application Number NL2011050219
Publication Number 2011/122948
Status In Force
Filing Date 2011-04-01
Publication Date 2011-10-06
Owner FUTURE DIAGNOSTICS B.V. (Netherlands)
Inventor
  • Martens, Michaël Franciscus Wilhelmus Cornelis
  • Parsons, George Henry
  • Rosmalen, Franciscus Maria Anna
  • Swinkels, Leon Maria Jacobus Wilhelmus

Abstract

Disclosed is the invention to conduct immuno-adsorption of free 25(OH) vitamin D from blood or blood components, notably serum or plasma, after which the absorbed material is measured. A fluoro-alkyl surfactant is used to enhance the solubility of Vitamin D and allow the measurement of free Vitamin D. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.

IPC Classes  ?

  • G01N 33/82 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving vitamins